LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Peptide containing doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glutathione delivery system

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glutathione derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glutathione N-hydroxycarbamoyl thioesters and method of inhibiti

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glutathione S-transferase-activated compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glutathione-based delivery system

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glycoconjugate inhibition of Streptococcus pyrogenes adhesion

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glycoconjugates including more than one peptide

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glycoconjugation methods and proteins/peptides produced by...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glycogen synthase kinase-3 inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glycogen synthase kinase-3 inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glycogen synthase kinase-3 inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glycogen synthase kinase-3 inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glycolic acid derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glycopegylated erythropoietin

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glycopegylated erythropoietin

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glycopegylated erythropoietin formulations

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glycopegylated granulocyte colony stimulating factor

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glycopegylation methods and proteins/peptides produced by...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Glycopegylation methods and proteins/peptides produced by...